FMR LLC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 315066 BOSTON, MA

Back to ACAD Full portfolio

Position in ACAD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$7,798,568

-$11,618,612 QoQ

Shares Held

350,340

-51.8% QoQ

Ownership

0.205%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 95.27059427984244.ToString("F0")% Shared 0.ToString("F0")% None 4.729405720157561.ToString("F0")%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

FMR LLC holds $49,682,018,247 across 354 Biotechnology names. ACAD ranks #152 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	14,579,166	$4,823,808,652
2	ARGX	Argenx SE	4,991,034	$3,644,702,577
3	MRNA	Moderna, Inc.	45,672,024	$2,320,138,818
4	ROIV	Roivant Sciences Ltd.	77,981,253	$2,160,080,705
5	INSM	INSMED Inc	13,160,167	$2,151,950,504
6	IONS	Ionis Pharmaceuticals Inc	24,556,637	$1,843,957,869
7	RPRX	Royalty Pharma plc	25,152,242	$1,206,553,046
8	REGN	Regeneron Pharmaceuticals, Inc.	1,518,192	$1,173,015,865

All Filings in ACAD

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,798,568	350,340	-51.8%	Shares	Defined	2026-05-15
2025-12-31	$19,417,180	726,963	+9.2%	Shares	Defined	2026-02-17
2025-09-30	$14,208,384	665,810	+293.1%	Shares	Defined	2025-11-13
2025-06-30	$3,653,137	169,362	-2.8%	Shares	Defined	2025-08-14
2025-03-31	$2,894,308	174,251	+26.2%	Shares	Defined	2025-05-12
2024-12-31	$2,532,758	138,025	+41.8%	Shares	Defined	2025-02-13
2024-09-30	$1,497,365	97,358	-95.9%	Shares	Defined	2024-11-13
2024-06-30	$38,463,360	2,366,976	-40.7%	Shares	Defined	2024-08-13
2024-03-31	$73,845,470	3,993,806	-24.1%	Shares	Defined	2024-05-13
2023-12-31	$164,858,358	5,265,358	-0.7%	Shares	Defined	2024-02-13
2023-09-30	$110,493,262	5,301,980	-0.4%	Shares	Defined	2023-11-13
2023-06-30	$127,443,624	5,321,237	-32.2%	Shares	Defined	2023-08-11
2023-03-31	$147,674,385	7,846,673	-15.9%	Shares	Defined	2023-08-11
2022-12-31	$148,607,052	9,334,614	-19.3%	Shares	Defined	2023-02-13
2022-09-30	$189,301,968	11,571,025	-6.7%	Shares	Defined	2022-11-10
2022-06-30	$174,701,303	12,398,957	-8.0%	Shares	Defined	2022-08-12
2022-03-31	$326,520,694	13,481,449	-2.6%	Shares	Defined	2022-05-13
2021-12-31	$323,043,104	13,840,750	-12.8%	Shares	Defined	2022-02-14
2021-09-30	$263,709,395	15,876,544	+2.4%	Shares	Defined	2022-02-14
2021-06-30	$378,023,975	15,499,138	-9.8%	Shares	Defined	2021-08-13
2021-03-31	$443,437,060	17,187,483	-11.7%	Shares	Defined	2021-05-14
2020-12-31	$1,041,021,981	19,472,914	-1.4%	Shares	Defined	2021-02-08
2020-09-30	$814,619,354	19,748,348	-5.0%	Shares	Defined	2020-11-13
2020-06-30	$1,007,706,033	20,790,304	+2.5%	Shares	Defined	2020-08-24
2020-03-31	$857,290,398	20,290,897	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.